Market Cap: $28.57B
Market Cap: $28.57B

Quest Diagnostics (Ticker: DGX) marks a significant milestone in oncology diagnostics with the recent approval of its Haystack MRD liquid biopsy test. The New York State Department of Health's Clinica…

Quest Diagnostics significantly enhances its drug screening capabilities to meet evolving regulatory demands and capitalize on market opportunities. Innovative Drug Screening Enhancements The company…
Transforming AI Workflows in Diagnostics: Quali's Integration with NVIDIA In the fast-evolving landscape of artificial intelligence and healthcare diagnostics, the integration of Quali's Torque platfo…
Quest Diagnostics Leverages AI Workflows Through Strategic Collaborations In recent developments within the healthcare diagnostics sector, Quest Diagnostics stands at the forefront of integrating adva…
Quest Diagnostics Strengthens Leadership with New Board Appointment Quest Diagnostics Incorporated, a leading provider of diagnostic information services, enhances its leadership team by appointing Ti…
### Quest Diagnostics Welcomes Healthcare Visionary to Board Quest Diagnostics Incorporated has strategically enhanced its governance structure by appointing Timothy (Tim) Wentworth to its board of di…
Empowering Patient Engagement: Quest Diagnostics Launches AI Companion Quest Diagnostics, a prominent figure in diagnostic information services, introduces its latest innovation, Quest AI Companion, d…
Unlocking Health Insights: Quest Diagnostics Launches AI Companion Quest Diagnostics, a frontrunner in diagnostic information services, introduces the Quest AI Companion, an innovative AI-powered chat…
Quest Diagnostics Names New Senior Vice President to Accelerate Growth Strategy Quest Diagnostics announces the appointment of Benjamin Beauvalot as Senior Vice President, Chief Strategy and M&A Offic…
Quest Diagnostics Strengthens Commitment to Healthcare Innovation Quest Diagnostics Incorporated, a leading entity in diagnostic information services, is poised to spotlight its strategic growth and m…
Quest Diagnostics Amplifies Healthcare Insights at Leerink Global Conference Quest Diagnostics Incorporated, a frontline leader in diagnostic information services, is gearing up for a significant pres…
Quest Diagnostics Prepares to Discuss Strategic Vision at Upcoming Healthcare Conference Quest Diagnostics Incorporated, a leading entity in diagnostic information services, is poised to showcase its…
Headline: Quest Diagnostics braces for volume and cost shifts as U.S. jobs and inflation data loom Main topic — Testing volumes and margins in focus as labor, inflation reports approach Quest Diagnost…
Labor and cost pressures for Quest Diagnostics as U.S. jobs and inflation prints approach Quest Diagnostics faces renewed operational pressure as two key U.S. economic reports due next week — January…
Barclays signals renewed faith in Quest Diagnostics' testing business NEW YORK — Barclays upgrades Quest Diagnostics to "Overweight," raising its price target to $210, a move that reflects growing ana…
Barclays Upgrade Casts Light on Diagnostics Sector Confidence Analysts are sharpening focus on the clinical laboratory sector as Barclays moves Quest Diagnostics into an "Overweight" stance. The call…
Quest Diagnostics Earns Esteemed Recognition for Excellence in Healthcare Services Quest Diagnostics, a leading provider of diagnostic information services, continues to affirm its position as an indu…
Quest Diagnostics Achieves Esteemed Recognition for Commitment to Healthcare Excellence Quest Diagnostics, a leader in diagnostic information services, earns a prestigious spot on Fortune magazine's 2…
Quest Diagnostics: A Leader in Diagnostic Innovation and Social Responsibility Quest Diagnostics stands out in the healthcare landscape as it earns a spot on Fortune magazine's 2026 World's Most Admir…
Leadership Transition at Sonora Quest Laboratories Promises Continuity and Growth Sonora Quest Laboratories has recently announced the appointment of Jennifer Erickson as Chief Executive Officer-Elect…
Leadership Transition Signals Continued Growth at Sonora Quest Laboratories Sonora Quest Laboratories announces the appointment of Jennifer Erickson as Chief Executive Officer-Elect, set to succeed Da…
Advancements in Cancer Detection: Quest Diagnostics' Focus on ctDNA Testing Quest Diagnostics, a leader in diagnostic information services, prepares to present groundbreaking findings on circulating t…
Quest Diagnostics Advances Cancer Monitoring with ctDNA Technology Quest Diagnostics, a leading provider of diagnostic information services, prepares to present groundbreaking research on circulating…
Quest Diagnostics Advances Cancer Monitoring with Innovative ctDNA Testing Quest Diagnostics, a key player in diagnostic information services, is poised to make significant contributions to cancer man…
Quest Diagnostics Prepares for Key Presentation at J.P. Morgan Healthcare Conference Quest Diagnostics Incorporated, a leading provider of diagnostic information services, is set to showcase its strat…
Quest Diagnostics Set to Showcase Strategic Vision at J.P. Morgan Healthcare Conference Quest Diagnostics Incorporated, a leading provider of diagnostic information services, prepares to take center s…
Quest Diagnostics Faces Increased Short Interest Amid Market Sentiment Shift Quest Diagnostics Inc. is currently experiencing a significant rise in short interest, with recent reports indicating a 16.…
Quest Diagnostics Faces Rising Short Interest Amid Market Sentiment Quest Diagnostics Inc, a leading provider of diagnostic testing services, finds itself in a challenging market environment as recent…
Quest Diagnostics Navigates Competitive Landscape Amidst Industry Challenges Quest Diagnostics, a leader in diagnostic testing and healthcare solutions, continues to assert its relevance in an increas…
Navigating Competitive Challenges in Telehealth: Insights from Hims & Hers Health Inc. Hims & Hers Health Inc. faces a challenging landscape in the rapidly evolving telehealth sector, where competitiv…
Revolutionizing Health Management: Hims & Hers Launches Innovative Labs Platform In a significant development in the healthcare technology sector, Hims & Hers Health, Inc. unveils its new platform, La…
Hims & Hers Launches Labs: Transforming Health Insights for Users Hims & Hers Health, Inc. has unveiled a new platform called Labs, designed to empower individuals in their health journeys with person…
Quest Diagnostics Declares Dividend Amidst Commitment to Health Innovation Quest Diagnostics, a leading provider in diagnostic information services, makes headlines as it announces a quarterly cash di…
Quest Diagnostics Declares Quarterly Dividend Amidst Commitment to Enhancing Health Outcomes Quest Diagnostics, a leading figure in the diagnostic information services sector, announces its Board of D…
Quest Diagnostics Reinforces Commitment to Public Health with Dividend Declaration and Innovation in Diagnostics Quest Diagnostics, a leader in diagnostic information services, recently announces a qu…
Quest Diagnostics Embraces AI Revolution with New Automation Integration Quest Diagnostics, a leading provider of diagnostic information services, stands to benefit significantly from the recent integ…
Quest Diagnostics Enhances AI Capabilities with New Integration Quest Diagnostics stands at the forefront of healthcare innovation as it leverages cutting-edge technology to improve diagnostic service…
Cigna Group’s Upcoming Earnings: A Crucial Moment for Strategic Insights Cigna Group is poised to announce its quarterly earnings on October 30, 2025, an event that holds significant importance for st…
Quest Diagnostics Enhances Telehealth Services Amid Industry Transformation Quest Diagnostics, a leading provider of diagnostic information services, is at the forefront of adapting to the rapid evolu…
Quest Diagnostics Advances Alzheimer's Diagnostics with Innovative Blood Tests Quest Diagnostics has made significant strides in the early diagnosis of Alzheimer's disease through the development of t…
Quest Diagnostics Pioneers Blood-Based Alzheimer’s Tests, Enhancing Diagnostic Accuracy Quest Diagnostics has made a significant advancement in Alzheimer’s disease diagnosis with the development of tw…
Quest Diagnostics' Partnership Enhances Cancer Monitoring with Innovative Blood Test Quest Diagnostics solidifies its position in the oncology diagnostics sector through the introduction of the HPH MR…
Quest Diagnostics Eyes AI Innovation Amid European Advancements In the rapidly evolving landscape of healthcare technology, Quest Diagnostics is poised to benefit from significant advancements in arti…
Quest Diagnostics' Strategic Focus Drives Strong Third-Quarter Performance Quest Diagnostics reports robust financial results for the third quarter, showcasing the effectiveness of its strategic initi…
Quest Diagnostics Strengthens Its Position Amid Evolving Healthcare Landscape Quest Diagnostics is positioned at a pivotal moment in the healthcare sector as it prepares for its upcoming quarterly ear…
Quest Diagnostics Charts a Path Forward with Strategic Growth Initiatives Quest Diagnostics, a leader in the diagnostic testing industry, prepares to navigate a competitive landscape as it discloses i…
Innovative Blood Test for Cancer Detection Launched in Germany In a significant advancement in cancer diagnostics, the MVZ HPH Institute for Pathology and Hematopathology GmbH in Hamburg, Germany, has…
Advancements in Cancer Detection: HPH MRD Test Revolutionizes Patient Care The recent launch of the HPH MRD test by the MVZ HPH Institute for Pathology and Hematopathology GmbH in Hamburg represents a…
Quest Diagnostics: Navigating Complex Market Dynamics in Healthcare Quest Diagnostics, a leading provider of diagnostic testing solutions, finds itself at a pivotal moment as analysts evaluate its per…
Navigating Market Sentiment: Quest Diagnostics’ Position in the Healthcare Landscape In the latest quarter, Quest Diagnostics finds itself at a crossroads, evidenced by the insights of seven analysts…